 | • レポートコード：GIR201106213 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、変形性関節症鎮痛剤の世界市場を調査対象にし、変形性関節症鎮痛剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口、注射、外用）、用途別分析（医療、パーソナルケア）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Johnson & Johnson、Bayer、Mylan、Pfizer、Abbott Laboratories、GlaxoSmithKline、TEVA、Sanofi、Lilly、Almatica Pharma、Iroko Pharmaceuticals ・メーカー別販売量、売上、市場シェア ・変形性関節症鎮痛剤の地域別市場分析 ・変形性関節症鎮痛剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・変形性関節症鎮痛剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・変形性関節症鎮痛剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・変形性関節症鎮痛剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・変形性関節症鎮痛剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・変形性関節症鎮痛剤の種類別市場規模2015-2020：経口、注射、外用 ・変形性関節症鎮痛剤の用途別市場規模2015-2020：医療、パーソナルケア ・変形性関節症鎮痛剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Osteoarthritis Pain Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Osteoarthritis Pain Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 10560 million by 2025, from USD 8535.5 million in 2019.
Market segmentation
Osteoarthritis Pain Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Osteoarthritis Pain Drugs market has been segmented into
Oral
Injection
External
By Application, Osteoarthritis Pain Drugs has been segmented into:
Medical Care
Personal Care
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Osteoarthritis Pain Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Osteoarthritis Pain Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Osteoarthritis Pain Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Osteoarthritis Pain Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Osteoarthritis Pain Drugs Market Share Analysis
Osteoarthritis Pain Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Osteoarthritis Pain Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Osteoarthritis Pain Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Osteoarthritis Pain Drugs are:
Johnson & Johnson
Bayer
Mylan
Pfizer
Abbott Laboratories
GlaxoSmithKline
TEVA
Sanofi
Lilly
Almatica Pharma
Iroko Pharmaceuticals
Among other players domestic and global, Osteoarthritis Pain Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Osteoarthritis Pain Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Osteoarthritis Pain Drugs, with price, sales, revenue and global market share of Osteoarthritis Pain Drugs in 2018 and 2019.
Chapter 3, the Osteoarthritis Pain Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Osteoarthritis Pain Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Osteoarthritis Pain Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Osteoarthritis Pain Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Osteoarthritis Pain Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Osteoarthritis Pain Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Osteoarthritis Pain Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Overview of Global Osteoarthritis Pain Drugs Market
1.4.1 Global Osteoarthritis Pain Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan SWOT Analysis
2.3.4 Mylan Product and Services
2.3.5 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories SWOT Analysis
2.5.4 Abbott Laboratories Product and Services
2.5.5 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Product and Services
2.6.4 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 TEVA
2.7.1 TEVA Details
2.7.2 TEVA Major Business
2.7.3 TEVA Product and Services
2.7.4 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Product and Services
2.8.4 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business
2.9.3 Lilly Product and Services
2.9.4 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Almatica Pharma
2.10.1 Almatica Pharma Details
2.10.2 Almatica Pharma Major Business
2.10.3 Almatica Pharma Product and Services
2.10.4 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Iroko Pharmaceuticals
2.11.1 Iroko Pharmaceuticals Details
2.11.2 Iroko Pharmaceuticals Major Business
2.11.3 Iroko Pharmaceuticals Product and Services
2.11.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Osteoarthritis Pain Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Osteoarthritis Pain Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
4.5 South America Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Osteoarthritis Pain Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Osteoarthritis Pain Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Osteoarthritis Pain Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Osteoarthritis Pain Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
6.3 UK Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
6.4 France Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Osteoarthritis Pain Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
7.5 India Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Osteoarthritis Pain Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Osteoarthritis Pain Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Osteoarthritis Pain Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Osteoarthritis Pain Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Osteoarthritis Pain Drugs Price by Type (2015-2020)
11 Global Osteoarthritis Pain Drugs Market Segment by Application
11.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2015-2020)
11.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Osteoarthritis Pain Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Osteoarthritis Pain Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Osteoarthritis Pain Drugs Market Forecast (2021-2025)
12.2.2 Europe Osteoarthritis Pain Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Osteoarthritis Pain Drugs Market Forecast (2021-2025)
12.2.4 South America Osteoarthritis Pain Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Osteoarthritis Pain Drugs Market Forecast (2021-2025)
12.3 Osteoarthritis Pain Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Osteoarthritis Pain Drugs Market Share Forecast by Type (2021-2025)
12.4 Osteoarthritis Pain Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Osteoarthritis Pain Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Osteoarthritis Pain Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Osteoarthritis Pain Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Osteoarthritis Pain Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Osteoarthritis Pain Drugs Major Business
Table 10. Johnson & Johnson Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Johnson & Johnson SWOT Analysis
Table 12. Johnson & Johnson Osteoarthritis Pain Drugs Product and Services
Table 13. Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Bayer Basic Information, Manufacturing Base and Competitors
Table 15. Bayer Osteoarthritis Pain Drugs Major Business
Table 16. Bayer Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Bayer SWOT Analysis
Table 18. Bayer Osteoarthritis Pain Drugs Product and Services
Table 19. Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Mylan Basic Information, Manufacturing Base and Competitors
Table 21. Mylan Osteoarthritis Pain Drugs Major Business
Table 22. Mylan Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Mylan SWOT Analysis
Table 24. Mylan Osteoarthritis Pain Drugs Product and Services
Table 25. Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pfizer Basic Information, Manufacturing Base and Competitors
Table 27. Pfizer Osteoarthritis Pain Drugs Major Business
Table 28. Pfizer Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Pfizer SWOT Analysis
Table 30. Pfizer Osteoarthritis Pain Drugs Product and Services
Table 31. Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 33. Abbott Laboratories Osteoarthritis Pain Drugs Major Business
Table 34. Abbott Laboratories Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Abbott Laboratories SWOT Analysis
Table 36. Abbott Laboratories Osteoarthritis Pain Drugs Product and Services
Table 37. Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Osteoarthritis Pain Drugs Major Business
Table 40. GlaxoSmithKline Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 41. GlaxoSmithKline SWOT Analysis
Table 42. GlaxoSmithKline Osteoarthritis Pain Drugs Product and Services
Table 43. GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. TEVA Basic Information, Manufacturing Base and Competitors
Table 45. TEVA Osteoarthritis Pain Drugs Major Business
Table 46. TEVA Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 47. TEVA SWOT Analysis
Table 48. TEVA Osteoarthritis Pain Drugs Product and Services
Table 49. TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Sanofi Basic Information, Manufacturing Base and Competitors
Table 51. Sanofi Osteoarthritis Pain Drugs Major Business
Table 52. Sanofi Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Sanofi SWOT Analysis
Table 54. Sanofi Osteoarthritis Pain Drugs Product and Services
Table 55. Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Lilly Basic Information, Manufacturing Base and Competitors
Table 57. Lilly Osteoarthritis Pain Drugs Major Business
Table 58. Lilly Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 59. Lilly SWOT Analysis
Table 60. Lilly Osteoarthritis Pain Drugs Product and Services
Table 61. Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 63. Almatica Pharma Osteoarthritis Pain Drugs Major Business
Table 64. Almatica Pharma Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Almatica Pharma SWOT Analysis
Table 66. Almatica Pharma Osteoarthritis Pain Drugs Product and Services
Table 67. Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Major Business
Table 70. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Total Revenue (USD Million) (2018-2019)
Table 71. Iroko Pharmaceuticals SWOT Analysis
Table 72. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product and Services
Table 73. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Osteoarthritis Pain Drugs Sales by Manufacturer (2018-2019) (M Dose)
Table 75. Global Osteoarthritis Pain Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Osteoarthritis Pain Drugs Sales by Regions (2015-2020) (M Dose)
Table 77. Global Osteoarthritis Pain Drugs Sales Market Share by Regions (2015-2020)
Table 78. Global Osteoarthritis Pain Drugs Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Osteoarthritis Pain Drugs Sales by Countries (2015-2020) (M Dose)
Table 80. North America Osteoarthritis Pain Drugs Sales Market Share by Countries (2015-2020)
Table 81. North America Osteoarthritis Pain Drugs Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2015-2020)
Table 83. Europe Osteoarthritis Pain Drugs Sales by Countries (2015-2020) (M Dose)
Table 84. Europe Osteoarthritis Pain Drugs Sales Market Share by Countries (2015-2020)
Table 85. Europe Osteoarthritis Pain Drugs Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Osteoarthritis Pain Drugs Sales by Regions (2015-2020) (M Dose)
Table 87. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Osteoarthritis Pain Drugs Sales by Countries (2015-2020) (M Dose)
Table 90. South America Osteoarthritis Pain Drugs Sales Market Share by Countries (2015-2020)
Table 91. South America Osteoarthritis Pain Drugs Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Osteoarthritis Pain Drugs Sales by Countries (2015-2020) (M Dose)
Table 94. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Osteoarthritis Pain Drugs Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Global Osteoarthritis Pain Drugs Sales by Type (2015-2020) (M Dose)
Table 98. Global Osteoarthritis Pain Drugs Sales Share by Type (2015-2020)
Table 99. Global Osteoarthritis Pain Drugs Revenue by Type (2015-2020) (USD Million)
Table 100. Global Osteoarthritis Pain Drugs Revenue Share by Type (2015-2020)
Table 101. Global Osteoarthritis Pain Drugs Sales by Application (2015-2020) (M Dose)
Table 102. Global Osteoarthritis Pain Drugs Sales Share by Application (2015-2020)
Table 103. Global Osteoarthritis Pain Drugs Sales Forecast by Regions (2021-2025) (M Dose)
Table 104. Global Osteoarthritis Pain Drugs Market Share Forecast by Regions (2021-2025)
Table 105. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2021-2025) (M Dose)
Table 106. Global Osteoarthritis Pain Drugs Market Share Forecast by Type (2021-2025)
Table 107. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2021-2025)
Table 108. Global Osteoarthritis Pain Drugs Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Osteoarthritis Pain Drugs Picture
Figure 2. Global Sales Market Share of Osteoarthritis Pain Drugs by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. External Picture
Figure 6. Osteoarthritis Pain Drugs Sales Market Share by Application in 2019
Figure 7. Medical Care Picture
Figure 8. Personal Care Picture
Figure 9. Global Osteoarthritis Pain Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Osteoarthritis Pain Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Osteoarthritis Pain Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Osteoarthritis Pain Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 35. Global Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Osteoarthritis Pain Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Osteoarthritis Pain Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Osteoarthritis Pain Drugs Sales Market Share by Countries in 2018
Figure 46. North America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 49. Canada Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 50. Mexico Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 51. Europe Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Osteoarthritis Pain Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 55. UK Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 56. France Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 57. Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 58. Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 59. Asia-Pacific Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Osteoarthritis Pain Drugs Revenue Market Share by Regions 2019
Figure 62. China Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 63. Japan Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 64. Korea Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 65. India Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 66. Southeast Asia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 67. South America Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Osteoarthritis Pain Drugs Sales Market Share by Countries in 2019
Figure 69. South America Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 71. Argentina Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 72. Middle East and Africa Osteoarthritis Pain Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 77. Egypt Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 78. Turkey Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 79. South Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2015-2020) (M Dose)
Figure 80. Global Osteoarthritis Pain Drugs Sales and Growth Rate (2021-2025) (M Dose)
Figure 81. Global Osteoarthritis Pain Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Osteoarthritis Pain Drugs Market Forecast (2021-2025) (M Dose)
Figure 83. Europe Sales Osteoarthritis Pain Drugs Market Forecast (2021-2025) (M Dose)
Figure 84. Asia-Pacific Sales Osteoarthritis Pain Drugs Market Forecast (2021-2025) (M Dose)
Figure 85. South America Sales Osteoarthritis Pain Drugs Market Forecast (2021-2025) (M Dose)
Figure 86. Middle East & Africa Sales Osteoarthritis Pain Drugs Market Forecast (2021-2025) (M Dose)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
変形性関節症苦痛治療薬の世界市場 2020年 Market Overview The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- 変形性関節症疼痛の世界市場 2020年 Market Overview The global Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis Pain marke…
- 鎮痛剤の世界市場 2020年 Market Overview The global Drugs for Pain Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Pain Mana…
- 変形性関節症用栄養・サプリメントの世界市場 2020年 Market Overview The Osteoarthritis Nutrition and Food Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 変形性膝関節症治療の世界市場 2020年 Market Overview The Knee Osteoarthritis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…